Galenix Drug Delivery Solutions, Drug Product Development, Licencing-Out Opportunities

Fact and Figures

  • Founded in 1993
  • 100% privately owned
  • CEO and main shareholder: M. Jérôme Besse
  • 20 employees
  • Two entities:
    • Galenix Innovations
    • Galenix Inc.

Services provided to health and biotech companies :

  • Patented Drug Delivery Systems for licensing out
  • Preformulation
  • Formulation development
  • Analytical development and validation
  • Quality Control
  • Stability studies
  • Clinical supply services support
  • Regulatory affairs
  • Products Registration Files for licensing out

Director : Jérôme BESSE, Legal Representative – jbesse@galenix.fr

FACTS :

  • Services :
    • Pharmaceutical contract services
    • Drug Product Development
    • Drug Delivery Solutions
    • Clinical supply services support
    • Consulting
    • Licensing-out